Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats

Journal of Neurosurgery

Volumn 87, Issue 4, 1997, Pages 595-601

  Belayev, Ludmila ^b   Busto, Raul ^b   Zhao, Weizhao ^b   Clemens, James A ^b   Ginsberg, Myron D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Albumin; Focal cerebral ischemia; Hemodilution; Neuroprotection; Rat; Stroke

Indexed keywords

HALOTHANE; HUMAN SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN PERFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HEMATOCRIT; HEMODILUTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

EID: 0030930227     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.87.4.0595     Document Type: Article

References (39)

1. Bederson JB, Pitts LH, Tsuji M, et al: Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472-476, 1986
2. Belayev L, Alonso OF, Busto R, et al: Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 27: 1616-1623, 1996
3. Belayev L, Busto R, Zhao W, et al: HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. Stroke 26:2313-2320, 1995
4. Chio CC, Ho MT, Huang CC, et al: Hypervolemic hemodilution may protect the rat's striatal neurons from ischemic injury by reducing the extracellular dopamine. Neurosci Lett 171: 5-8, 1994
5. Cole DJ, Drummond JC, Osborne TN, et al: Hypertension and hemodilution during cerebral ischemia reduce brain injury and edema. Am J Physiol 259:H211-H217, 1990
6. Cole DJ, Drummond JC, Patel PM, et al: Effects of viscosity and oxygen content on cerebral blood flow in ischemic and normal rat brain. J Neurol Sci 124:15-20, 1994
7. Cole DJ, Schell RM, Drummond JC, et al: Focal cerebral ischemia in rats: effect of hemodilution with α-α cross-linked hemoglobin on brain injury and edema. Can J Neurol Sci 20: 30-36, 1993
8. De Ryck M, van Reempts J, Borgers M, et al: Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarct in rats. Stroke 20:1383-1390, 1989
9. Emerson TE Jr: Unique features of albumin: a brief review. Crit Care Med 17:690-694, 1989
10. Fein JM: Comment on Wood JH, Simeone FA, Kron RE, et al: Experimental hypervolemic hemodilution: physiological correlations of cortical blood flow, cardiac output, and intracranial pressure with fresh blood viscosity and plasma volume. Neurosurgery 14:722-723, 1984
11. Gilroy J, Barnhart MI, Meyer JS: Treatment of acute stroke with dextran 40. JAMA 210:293-298, 1969
12. Ginsberg MD: Neuroprotection in brain ischemia: an update (Part I). Neuroscientist 1:95-103, 1995
13. Ginsberg MD: Neuroprotection in brain ischemia: an update (Part II). Neuroscientist 1:164-175, 1995
14. Goslinga H, Eijzenbach V, Heuvelmans JHA, et al: Custom-tailored hemodilution with albumin and crystalloids in acute ischemic stroke. Stroke 23:181-188, 1992
15. Grotta JC: Current status of hemodilution in acute cerebral ischemia. Stroke 18:689-690, 1987
16. Italian Acute Stroke Study Group: Haemodilution in acute stroke: results of the Italian Haemodilution Trial. Lancet 1: 318-321, 1988
17. Koroshetz WJ, Moskowitz MA: Emerging treatments for stroke in humans. Trends Pharmacol Sci 17:227-233, 1996
18. Korosue K, Heros RC: Mechanism of cerebral blood flow augmentation by hemodilution in rabbits. Stroke 23:1487-1493, 1992
19. Kusunoki M, Kimura K, Nakamura M, et al: Effects of hematocrit variations on cerebral blood flow and oxygen transport in ischemic cerebrovascular disease. J Cereb Blood Flow Metab 1:413-417, 1981
20. Lee SH, Heros RC, Mullan JC, et al: Optimum degree of hemodilution for brain protection in a canine model of focal cerebral ischemia. J Neurosurg 80:469-475, 1994
21. Little JR, Slugg RM, Latchaw JP Jr, et al: Treatment of acute focal cerebral ischemia with concentrated albumin. Neurosurgery 9:552-558, 1981
22. Matsui T, Asano T: The hemodynamic effects of prolonged albumin administration in beagle dogs exposed to experimental subarachnoid hemorrhage. Neurosurgery 32:79-84, 1993
23. Matsui T, Sinyama H, Asano T: Beneficial effect of prolonged administration of albumin on ischemic cerebral edema and infarction after occlusion of middle cerebral artery in rats. Neurosurgery 33:293-300, 1993
24. 2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat. Neurology 38:1667-1673, 1988
25. Ohtaki M, Tranmer BI: Role of hypervolemic hemodilution in focal cerebral ischemia of rats. Surg Neurol 40:196-206, 1993
26. Oliff HS, Weber E, Eilon G, et al: The role of strain/vendor differences on the outcome of focal ischemia induced by intraluminal middle cerebral artery occlusion in the rat. Brain Res 675:20-26, 1995
27. Paczynski RP, Diringer MN, Hsu CY: Experimental therapies to improve delivery of oxygen and substrate in acute stroke. Curr Opin Neurol 8:6-14, 1995
28. Scandinavian Stroke Study Group: Multicenter trial of hemodilution in acute ischemic stroke: I. Results in the total patient population. Stroke 18:691-699, 1987
29. Strand T: Evaluation of long-term outcome and safety after hemodilution therapy in acute ischemic stroke. Stroke 23: 657-662, 1992
30. Sundt TM Jr, Waltz AG, Sayre GP: Experimental cerebral infarction: modification by treatment with hemodiluting, hemoconcentrating, and dehydrating agents. J Neurosurg 26:46-56, 1967
31. Swanson RA, Morton MT, Tsao-Wu G, et al: A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-293, 1990
32. Tu YK, Heros RC, Candia G, et al: Isovolemic hemodilution in experimental focal cerebral ischemia. Part 1: effects on hemodynamics, hemorheology, and intracranial pressure. J Neurosurg 69:72-81, 1988
33. Tu YK, Heros RC, Karacostas D, et al: Isovolemic hemodilution in experimental focal cerebral ischemia. Part 2: effects on regional cerebral blood flow and size of infarction. J Neurosurg 69:82-91, 1988
34. Wood JH, Fleischer AS: Observation during hypervolemic hemodilution of patients with acute focal cerebral ischemia. JAMA 248:2999-3004, 1982
35. Wood JH, Kee DB Jr: Hemorheology of the cerebral circulation in stroke. Stroke 16:765-772, 1985
36. Wood JH, Simeone FA, Fink EA, et al: Hypervolemic hemodilution in experimental focal cerebral ischemia. Evaluation of cardiac output, regional cortical blood flow, and ICP after intravascular volume expansion with low molecular weight dextran. J Neurosurg 59:500-509, 1983
37. Yanaka K, Camarata PJ, Spellman SR, et al: Optimal timing of hemodilution for brain protection in a canine model of focal cerebral ischemia. Stroke 27:906-912, 1996
38. Zea Longa E, Weinstein PR, Carlson S, et al: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91, 1989
39. Zhao W, Ginsberg MD, Prado R, et al: Depiction of infarct frequency distribution by computer-assisted image mapping in rat brains with middle cerebral artery occlusion. Comparison of photothrombotic and intraluminal suture models. Stroke 27: 1112-1117, 1996